Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 68INDUSTRY 27NIH 5OTHER_GOV 2NETWORK 1INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 1Lymphoma, Non-Hodgkin 1

Interventions

Proflavine 9pembrolizumab 2Tacrolimus 2Pyridostigmine Bromide 2Prednisone 2Microbial Collagenase 2sargramostim 1plerixafor 1pegfilgrastim 1olaparib 1nilotinib 1macimorelin 1keyhole-limpet hemocyanin 1ethyl pyruvate 1compound W 1blinatumomab 1Watchful Waiting 1Uracil 1Tegafur 1Surgical Procedures, Operative 1Steroids 1Sodium Chloride 1Sirolimus 1Salicylates 1Peptides 1PM 01183 1Mycophenolic Acid 1Monatide (IMS 3015) 1Mifepristone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDIV × plerixafor × Clear all
NCT01042717 2011-09-27

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Shi, Patricia, M.D.

Phase NA Unknown
10 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡